Therapy Improved Outcomes for Survivors of Cancer
Researchers sought to determine if fear of recurrence therapy could improve outcomes for survivors of breast and gynecologic cancers.
Researchers sought to determine if fear of recurrence therapy could improve outcomes for survivors of breast and gynecologic cancers.
The conversion to regular approval was based on data from an additional 141 patients with dMMR recurrent or advanced endometrial cancer who had progressed on or after a platinum-containing regimen.
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Centers that perform comprehensive cancer screening in a single appointment may enable earlier cancer diagnosis.
Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Residential racial and economic segregation across US counties is associated with higher cancer mortality, a study suggests.
The decision to restrict the indication follows an FDA review of the double-blind, placebo-controlled phase 3 ENGOT-OV16/NOVA trial.
The approval was based on data from the SORAYA trial.
A quarter of patients with gynecologic cancer required prior authorization by their insurance for some part of their cancer care, resulting in a delay or change in care.